Published in J Biol Chem on September 29, 2000
(N)-methanocarba 2,N6-disubstituted adenine nucleosides as highly potent and selective A3 adenosine receptor agonists. J Med Chem (2005) 1.54
Polycyclic compounds: ideal drug scaffolds for the design of multiple mechanism drugs? Neurotherapeutics (2009) 1.53
Functionalized congener approach to the design of ligands for G protein-coupled receptors (GPCRs). Bioconjug Chem (2009) 1.15
Design of (N)-methanocarba adenosine 5'-uronamides as species-independent A3 receptor-selective agonists. Bioorg Med Chem Lett (2008) 1.07
Tumor necrosis factor alpha-induced apoptosis in astrocytes is prevented by the activation of P2Y6, but not P2Y4 nucleotide receptors. Biochem Pharmacol (2003) 1.04
The ultra-potent and selective TLR8 agonist VTX-294 activates human newborn and adult leukocytes. PLoS One (2013) 1.03
Characterization of ERK1/2 signalling pathways induced by adenosine receptor subtypes in newborn rat cardiomyocytes. Br J Pharmacol (2004) 1.00
Molecular modeling of a PAMAM-CGS21680 dendrimer bound to an A2A adenosine receptor homodimer. Bioorg Med Chem Lett (2008) 0.94
Semi-rational design of (north)-methanocarba nucleosides as dual acting A(1) and A(3) adenosine receptor agonists: novel prototypes for cardioprotection. J Med Chem (2005) 0.89
GPCR ligand dendrimer (GLiDe) conjugates: adenosine receptor interactions of a series of multivalent xanthine antagonists. Bioconjug Chem (2011) 0.86
Adenosine amine congener mitigates noise-induced cochlear injury. Purinergic Signal (2010) 0.85
Synthesis and purine receptor affinity of 6-oxopurine nucleosides and nucleotides containing (N)-methanocarba-pseudoribose rings. Bioorg Med Chem Lett (2001) 0.80
Structure-guided development of heterodimer-selective GPCR ligands. Nat Commun (2016) 0.79
Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol (1973) 47.81
Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation (1986) 19.82
[3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain. J Pharmacol Exp Ther (1989) 4.18
125I-4-aminobenzyl-5'-N-methylcarboxamidoadenosine, a high affinity radioligand for the rat A3 adenosine receptor. Mol Pharmacol (1994) 2.65
Characterization of adenosine receptors in rat brain by (-)[3H]N6-phenylisopropyladenosine. Naunyn Schmiedebergs Arch Pharmacol (1980) 2.32
Functionalized congeners of adenosine: preparation of analogues with high affinity for A1-adenosine receptors. J Med Chem (1985) 2.12
Myocardial protection with preconditioning. Circulation (1990) 1.83
Adenosine A3 receptors: novel ligands and paradoxical effects. Trends Pharmacol Sci (1998) 1.79
Protective effects of adenosine in myocardial ischemia. Circulation (1992) 1.66
A physiological role of the adenosine A3 receptor: sustained cardioprotection. Proc Natl Acad Sci U S A (1998) 1.63
Direct preconditioning of cultured chick ventricular myocytes. Novel functions of cardiac adenosine A2a and A3 receptors. J Clin Invest (1996) 1.57
A functionalized congener approach to adenosine receptor antagonists: amino acid conjugates of 1,3-dipropylxanthine. Mol Pharmacol (1986) 1.55
A novel cardioprotective function of adenosine A1 and A3 receptors during prolonged simulated ischemia. Am J Physiol (1997) 1.27
ATP-sensitive potassium channels and myocardial preconditioning. Basic Res Cardiol (1995) 1.19
Selective adenosine A3 receptor stimulation reduces ischemic myocardial injury in the rabbit heart. Cardiovasc Res (1997) 1.19
High affinity acylating antagonists for the A1 adenosine receptor: identification of binding subunit. Mol Pharmacol (1988) 1.17
Distinct cardioprotective effects of adenosine mediated by differential coupling of receptor subtypes to phospholipases C and D. FASEB J (2000) 1.12
Cardiac myocytes rendered ischemia resistant by expressing the human adenosine A1 or A3 receptor. FASEB J (1998) 1.04
Ischemic preconditioning Nature's own cardioprotective intervention. Trends Cardiovasc Med (2011) 0.99
Evidence of spare A1-adenosine receptors in guinea pig atrioventricular node. Am J Physiol (1992) 0.97
Direct preconditioning of cardiac ventricular myocytes via adenosine A1 receptor and KATP channel. Am J Physiol (1996) 0.92
Comparative molecular field analysis of selective A3 adenosine receptor agonists. Bioorg Med Chem (1995) 0.87
Protein kinase C-dependent activation of KATP channel enhances adenosine-induced cardioprotection. Biochem J (1998) 0.85
A novel method of identifying living transfected cardiac myocyte. Nucleic Acids Res (1996) 0.85
Binary drugs: conjugates of purines and a peptide that bind to both adenosine and substance P receptors. J Med Chem (1987) 0.82
The metabolism of naphthalene in rabbits. Biochem J (1934) 31.93
Synthesis of l-alpha-naphthylmercapturic acid. Biochem J (1934) 12.42
Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest (1999) 7.69
A novel class of evolutionarily conserved genes defined by piwi are essential for stem cell self-renewal. Genes Dev (1998) 6.74
Genetic control of programmed cell death in Drosophila. Science (1994) 6.08
Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science (1996) 5.55
The DNA sequence and analysis of human chromosome 6. Nature (2003) 4.75
Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry (2001) 4.37
Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry (2001) 4.13
Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. JAMA (1995) 4.02
T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years. Science (1995) 3.87
c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J Clin Invest (2001) 3.86
Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes. J Virol (1990) 3.54
Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J Neurosci (2001) 3.46
High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype. Arch Neurol (1998) 2.77
JNK2 and IKKbeta are required for activating the innate response to viral infection. Immunity (1999) 2.74
Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact. Aliment Pharmacol Ther (2005) 2.71
Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease. Ann Neurol (1995) 2.62
Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site. Proc Natl Acad Sci U S A (1991) 2.61
Defective neural tube morphogenesis and altered apoptosis in the absence of both JNK1 and JNK2. Mech Dev (1999) 2.56
Isolation and characterization of new fission yeast cytokinesis mutants. Genetics (1998) 2.51
Novel transcription from the Epstein-Barr virus terminal EcoRI fragment, DIJhet, in a nasopharyngeal carcinoma. J Virol (1990) 2.43
Evidence for long-term neurotoxicity associated with methamphetamine abuse: A 1H MRS study. Neurology (2000) 2.26
V. Stress and irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol (2001) 2.19
Safety and tolerability of rifaximin for the treatment of irritable bowel syndrome without constipation: a pooled analysis of randomised, double-blind, placebo-controlled trials. Aliment Pharmacol Ther (2014) 2.17
Vaccination with soluble Abeta oligomers generates toxicity-neutralizing antibodies. J Neurochem (2001) 2.14
Liver disease in patients with hereditary hemorrhagic telangiectasia. N Engl J Med (2000) 2.14
Prostate cancer risk and serum levels of insulin and leptin: a population-based study. J Natl Cancer Inst (2001) 2.12
Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis (2008) 2.12
Self-reported prevalence of asthma symptoms in children in Australia, England, Germany and New Zealand: an international comparison using the ISAAC protocol. Eur Respir J (1993) 2.07
Relationship of alveolar epithelial injury and repair to the induction of pulmonary fibrosis. Am J Pathol (1988) 2.01
Prospective comparison treatment of 595-nm pulsed-dye lasers for virgin port-wine stain. Br J Dermatol (2015) 1.96
Repetitive sigmoid stimulation induces rectal hyperalgesia in patients with irritable bowel syndrome. Gastroenterology (1997) 1.94
Antigen retrieval technique utilizing citrate buffer or urea solution for immunohistochemical demonstration of androgen receptor in formalin-fixed paraffin sections. J Histochem Cytochem (1993) 1.91
Biochemical studies of toxic agents. Metabolic ring-fission of cis- and trans-acenaphthene-1,2-diol. Biochem J (1966) 1.91
Enterobactin-mediated iron transport in Pseudomonas aeruginosa. J Bacteriol (1990) 1.90
Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders. Aliment Pharmacol Ther (2012) 1.79
Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's disease. Neurology (1997) 1.78
Lower diffusion in white matter of children with prenatal methamphetamine exposure. Neurology (2009) 1.76
The Visceral Sensitivity Index: development and validation of a gastrointestinal symptom-specific anxiety scale. Aliment Pharmacol Ther (2004) 1.76
Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis. Circulation (1998) 1.65
Cerebral activation in patients with irritable bowel syndrome and control subjects during rectosigmoid stimulation. Psychosom Med (2001) 1.64
How to influence patient oral hygiene behavior effectively. J Dent Res (2009) 1.63
Characterization of newly emerging Newcastle disease virus isolates from the People's Republic of China and Taiwan. J Clin Microbiol (2001) 1.63
Review article: the treatment of functional abdominal bloating and distension. Aliment Pharmacol Ther (2011) 1.63
The role of the sid1p kinase and cdc14p in regulating the onset of cytokinesis in fission yeast. EMBO J (2000) 1.62
Time-resolved pump-probe experiments at the LCLS. Opt Express (2010) 1.61
Abnormal brain activation on functional MRI in cognitively asymptomatic HIV patients. Neurology (2002) 1.61
Biochemical studies of toxic agents. The metabolic formation of 1- and 2-menaphthylmercapturic acid. Biochem J (1968) 1.61
fMRI-acoustic noise alters brain activation during working memory tasks. Neuroimage (2005) 1.60
Biochemical studies of toxic agents. 15. The biosynthesis of ethylmercapturic acid sulphoxide. Biochem J (1964) 1.59
Direct preconditioning of cultured chick ventricular myocytes. Novel functions of cardiac adenosine A2a and A3 receptors. J Clin Invest (1996) 1.57
Enabling households to support successful migration of AIDS orphans in southern Africa. AIDS Care (2004) 1.55
Functional GI disorders: from animal models to drug development. Gut (2007) 1.55
Characterization of symptoms in irritable bowel syndrome with mixed bowel habit pattern. Neurogastroenterol Motil (2013) 1.55
Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers. Am J Psychiatry (2001) 1.52
Outcomes in African Americans and Hispanics with lupus nephritis. Kidney Int (2006) 1.52
Antigen retrieval immunohistochemistry under the influence of pH using monoclonal antibodies. J Histochem Cytochem (1995) 1.50
Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease. Gastroenterology (2001) 1.50
Identification of conserved, RpoS-dependent stationary-phase genes of Escherichia coli. J Bacteriol (1998) 1.49
Brain areas specific for attentional load in a motion-tracking task. J Cogn Neurosci (2001) 1.48
Impact of chronic gastrointestinal symptoms in diabetes mellitus on health-related quality of life. Am J Gastroenterol (2001) 1.47
Gender-related differences in IBS symptoms. Am J Gastroenterol (2001) 1.47
In vivo 1H MRS choline: correlation with in vitro chemistry/histology. Life Sci (1996) 1.46
Current practices and intention to provide alcohol-related health advice in primary dental care. Br Dent J (2011) 1.46
Severity in irritable bowel syndrome: a Rome Foundation Working Team report. Am J Gastroenterol (2011) 1.46
Studies on the biologic relationship of some murine leukemia viruses. Cancer Res (1966) 1.46
A national policy on asthma management for schools. The Asthma Special Interest Group, Thoracic Society of Australia and New Zealand. J Paediatr Child Health (1994) 1.45
Management of hypercholesterolemia: practice patterns for primary care providers and cardiologists. Am J Cardiol (1997) 1.45
Autoantibodies in systemic vasculitis. Aust N Z J Med (1991) 1.44
A beta-tubulin leucine cluster involved in microtubule assembly and paclitaxel resistance. J Biol Chem (1999) 1.43
Formation of mercapturic acids in rats after the administration of aralkyl esters. Biochem J (1970) 1.43
Practice-induced changes of brain function during visual attention: a parametric fMRI study at 4 Tesla. Neuroimage (2004) 1.42
Randomized phase II study of BR96-doxorubicin conjugate in patients with metastatic breast cancer. J Clin Oncol (1999) 1.41
Pyochelin-mediated iron transport in Pseudomonas aeruginosa: involvement of a high-molecular-mass outer membrane protein. Infect Immun (1991) 1.41
Correlation of symptom criteria with perception thresholds during rectosigmoid distension in irritable bowel syndrome patients. Am J Gastroenterol (2000) 1.38
Rabies encephalitis in a patient with no history of exposure. Hum Pathol (1993) 1.38
The role of focus groups in health education for cervical cancer among minority women. J Community Health (1990) 1.37
Initial experience with the Pascal photocoagulator: a pilot study of 75 procedures. Br J Ophthalmol (2008) 1.37
Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? Am J Obstet Gynecol (1992) 1.37
Sex specific alterations in autonomic function among patients with irritable bowel syndrome. Gut (2005) 1.37
Fragmented condensate ground state of trapped weakly interacting bosons in two dimensions. Phys Rev Lett (2001) 1.36
The risk for transmission of Mycobacterium tuberculosis at the bedside and during autopsy. Ann Intern Med (1995) 1.36
Progressive right frontotemporal degeneration: clinical, neuropsychological and SPECT characteristics. Dementia (1993) 1.35
Brain metabolite concentration and dementia severity in Alzheimer's disease: a (1)H MRS study. Neurology (2001) 1.35
The DNA sequence and analysis of human chromosome 13. Nature (2004) 1.33
Gender differences in the functional organization of the brain for working memory. Neuroreport (2000) 1.33
The factor structure of self-report DSM-III axis II symptoms and their relationship to clinicians' ratings. Am J Psychiatry (1990) 1.32
Derivatives of the triazoloquinazoline adenosine antagonist (CGS 15943) having high potency at the human A2B and A3 receptor subtypes. J Med Chem (1998) 1.31
Brain proton magnetic resonance spectroscopy in children exposed to methamphetamine in utero. Neurology (2001) 1.30
In-vitro clonogenic assay for predicting response of ovarian cancer to chemotherapy. Lancet (1980) 1.30
Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy. Radiology (1997) 1.30
Kinetic analyses of stability of simple and complex retroviral vectors. Virology (2001) 1.28
Canadian Researches on BAL (British Anti-Lewisite). Science (1946) 1.27
Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease. Neurology (1995) 1.27
A novel cardioprotective function of adenosine A1 and A3 receptors during prolonged simulated ischemia. Am J Physiol (1997) 1.27